Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer.
about
Innovation in metabolomics to improve personalized healthcareWhole body MRI: improved lesion detection and characterization with diffusion weighted techniquesTE = 32 ms vs TE = 100 ms echo-time (1)H-magnetic resonance spectroscopy in prostate cancer: Tumor metabolite depiction and absolute concentrations in tumors and adjacent tissues.Multiparametric MRI Apparent Diffusion Coefficient (ADC) Accuracy in Diagnosing Clinically Significant Prostate Cancer.The role of 3-tesla diffusion-weighted magnetic resonance imaging in selecting prostate cancer patients for active surveillanceAutomated prostate cancer detection via comprehensive multi-parametric magnetic resonance imaging texture feature models.Focal magnetic resonance guided focused ultrasound for prostate cancer: Initial North American experience.Two solutions for registration of ultrasound to MRI for image-guided prostate interventionsThe role of magnetic resonance imaging in delineating clinically significant prostate cancerIn vivo prostate cancer detection and grading using restriction spectrum imaging-MRI.MRI-targeted prostate biopsy: a review of technique and results.Multiparametric magnetic resonance imaging in the management and diagnosis of prostate cancer: current applications and strategies.Interpretation and reporting multiparametric prostate MRI: a primer for residents and novices.Multiparametric MRI of the prostate: diagnostic performance and interreader agreement of two scoring systems.Rapid in vivo apparent diffusion coefficient mapping of hyperpolarized (13) C metabolites.Multiparametric magnetic resonance imaging of the prostate-a basic tutorial.The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.Diffusion in prostate cancer detection on a 3T scanner: How many b-values are needed?Targeted biopsy based on ADC map in the detection and localization of prostate cancer: a feasibility study.Relationship between Gleason score and apparent diffusion coefficients of diffusion-weighted magnetic resonance imaging in prostate cancer patients.The Utility of Diffusion Weighted Imaging (DWI) Using Apparent Diffusion Coefficient (ADC) Values in Discriminating Between Prostate Cancer and Normal Tissue.Diagnosis of typical and atypical transition zone prostate cancer and its mimics at multiparametric prostate MRI.Comparison of PI-RADS 2, ADC histogram-derived parameters, and their combination for the diagnosis of peripheral zone prostate cancer.Practical aspects of prostate MRI: hardware and software considerations, protocols, and patient preparation.Non-Invasive Prostate Cancer Characterization with Diffusion-Weighted MRI: Insight from In silico Studies of a Transgenic Mouse Model.Satisfaction assessment with malleable prosthetic implant of Spectra (AMS) and Genesis (Coloplast) models.T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results.
P2860
Q26830021-054D9CBA-ACA6-4D1A-9F8C-80A9D58688C9Q30662431-35190C80-6025-431B-99A1-B4B4F4FF552BQ30986225-6D04B1B9-282E-4C04-AB6B-FBEE1BD4F7DDQ33770797-9E99CB98-44BE-4FC3-B004-5D02B5D5AD29Q34864876-E5A727B0-D0ED-4EC1-981D-D915F79F299CQ35737796-6FF8ED94-7CC2-40F7-85F9-4D39D40ED0B4Q36487178-E6D85624-9B23-45EC-BC73-03D99EA440C0Q36849125-72BC0D5F-6C28-44D3-B82E-AA2710FDECD5Q37580674-7909C942-EA43-45DD-A190-419DE711143BQ37685320-B956DC81-2FE8-4BD0-A57E-570F2140F88EQ38141793-0604CC43-5B4A-4506-92B7-E676EB2CF442Q38178850-97309815-5EB0-40E1-A5C0-026E44EE43E4Q38190885-84804714-BAA0-4F5D-88FC-2F50E54D82B2Q38786175-4466D53E-4F6E-4810-8220-96BA2D740F09Q38957381-1349D385-02E0-4328-BA6C-829C60D10391Q39446378-374C013F-F773-4E92-AF63-841D8AC30235Q40243618-AAD8E45C-D37F-4188-945E-2265CEC01FD8Q40887974-8CA4E7BA-3E91-4CFA-BCCB-AC8654660718Q41058922-2C813A94-E2FF-4727-A25D-CEB12B78C09BQ42120979-02E4E959-81C9-48B8-8A4F-B09176B8029FQ43056789-1FDE4FE5-949C-44EE-90B0-ED94DA59DF1CQ45053929-78436C2D-2F29-4911-AAEF-9C85C42752E7Q46094232-6FFD1E97-E338-41D6-A45B-F8AFAD05BCF2Q46567823-7F10EE4F-B5A8-48B1-BDA8-25868161E6EEQ47139773-FB34289C-C0A9-45E4-B28E-52726E686874Q51186493-8F34A519-A541-4739-A2C3-3E44D0B77F0FQ52942612-7C19C9AE-7760-450C-9B16-F9645E9C81DE
P2860
Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Correlation of Gleason scores ...... g findings of prostate cancer.
@en
Correlation of Gleason scores ...... g findings of prostate cancer.
@nl
type
label
Correlation of Gleason scores ...... g findings of prostate cancer.
@en
Correlation of Gleason scores ...... g findings of prostate cancer.
@nl
prefLabel
Correlation of Gleason scores ...... g findings of prostate cancer.
@en
Correlation of Gleason scores ...... g findings of prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
Correlation of Gleason scores ...... g findings of prostate cancer.
@en
P2093
Christopher King
Daniel Margolis
M Albert Thomas
Rajakumar Nagarajan
Robert Reiter
Steven Raman
P2860
P304
P356
10.1155/2012/374805
P577
2011-12-15T00:00:00Z